These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 30109319)
1. Design and synthesis of tailored human caseinolytic protease P inhibitors. Gronauer TF; Mandl MM; Lakemeyer M; Hackl MW; Meßner M; Korotkov VS; Pachmayr J; Sieber SA Chem Commun (Camb); 2018 Aug; 54(70):9833-9836. PubMed ID: 30109319 [TBL] [Abstract][Full Text] [Related]
2. Phenyl Esters Are Potent Inhibitors of Caseinolytic Protease P and Reveal a Stereogenic Switch for Deoligomerization. Hackl MW; Lakemeyer M; Dahmen M; Glaser M; Pahl A; Lorenz-Baath K; Menzel T; Sievers S; Böttcher T; Antes I; Waldmann H; Sieber SA J Am Chem Soc; 2015 Jul; 137(26):8475-83. PubMed ID: 26083639 [TBL] [Abstract][Full Text] [Related]
3. Identification and Characterization of Approved Drugs and Drug-Like Compounds as Covalent Sassetti E; Durante Cruz C; Tammela P; Winterhalter M; Augustyns K; Gribbon P; Windshügel B Int J Mol Sci; 2019 May; 20(11):. PubMed ID: 31159170 [TBL] [Abstract][Full Text] [Related]
4. α-Amino Diphenyl Phosphonates as Novel Inhibitors of Escherichia coli ClpP Protease. Moreno-Cinos C; Sassetti E; Salado IG; Witt G; Benramdane S; Reinhardt L; Cruz CD; Joossens J; Van der Veken P; Brötz-Oesterhelt H; Tammela P; Winterhalter M; Gribbon P; Windshügel B; Augustyns K J Med Chem; 2019 Jan; 62(2):774-797. PubMed ID: 30571121 [TBL] [Abstract][Full Text] [Related]
5. Development and characterization of improved β-lactone-based anti-virulence drugs targeting ClpP. Zeiler E; Korotkov VS; Lorenz-Baath K; Böttcher T; Sieber SA Bioorg Med Chem; 2012 Jan; 20(2):583-91. PubMed ID: 21855356 [TBL] [Abstract][Full Text] [Related]
6. The mechanism of caseinolytic protease (ClpP) inhibition. Gersch M; Gut F; Korotkov VS; Lehmann J; Böttcher T; Rusch M; Hedberg C; Waldmann H; Klebe G; Sieber SA Angew Chem Int Ed Engl; 2013 Mar; 52(10):3009-14. PubMed ID: 23361916 [No Abstract] [Full Text] [Related]
7. Design, synthesis and biological evaluation of novel amino acid ureido derivatives as aminopeptidase N/CD13 inhibitors. Su L; Jia Y; Zhang L; Xu Y; Fang H; Xu W Bioorg Med Chem; 2012 Jun; 20(12):3807-15. PubMed ID: 22607877 [TBL] [Abstract][Full Text] [Related]
8. Selective Activation of Human Caseinolytic Protease P (ClpP). Stahl M; Korotkov VS; Balogh D; Kick LM; Gersch M; Pahl A; Kielkowski P; Richter K; Schneider S; Sieber SA Angew Chem Int Ed Engl; 2018 Oct; 57(44):14602-14607. PubMed ID: 30129683 [TBL] [Abstract][Full Text] [Related]
9. A novel class of Plasmodial ClpP protease inhibitors as potential antimalarial agents. Mundra S; Thakur V; Bello AM; Rathore S; Asad M; Wei L; Yang J; Chakka SK; Mahesh R; Malhotra P; Mohmmed A; Kotra LP Bioorg Med Chem; 2017 Oct; 25(20):5662-5677. PubMed ID: 28917450 [TBL] [Abstract][Full Text] [Related]
10. Disruption of oligomerization and dehydroalanine formation as mechanisms for ClpP protease inhibition. Gersch M; Kolb R; Alte F; Groll M; Sieber SA J Am Chem Soc; 2014 Jan; 136(4):1360-6. PubMed ID: 24106749 [TBL] [Abstract][Full Text] [Related]
11. Mitochondrial ClpP activity is required for cisplatin resistance in human cells. Zhang Y; Maurizi MR Biochim Biophys Acta; 2016 Feb; 1862(2):252-64. PubMed ID: 26675528 [TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and cytotoxic activities of novel hybrid compounds between 2-phenylbenzofuran and imidazole. Yang XD; Wan WC; Deng XY; Li Y; Yang LJ; Li L; Zhang HB Bioorg Med Chem Lett; 2012 Apr; 22(8):2726-9. PubMed ID: 22440627 [TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and discovery of 5-hydroxyaurone derivatives as growth inhibitors against HUVEC and some cancer cell lines. Cheng H; Zhang L; Liu Y; Chen S; Cheng H; Lu X; Zheng Z; Zhou GC Eur J Med Chem; 2010 Dec; 45(12):5950-7. PubMed ID: 20974505 [TBL] [Abstract][Full Text] [Related]
14. Novel potent 2,5-pyrrolidinedione peptidomimetics as aminopeptidase N inhibitors. Design, synthesis and activity evaluation. Li Q; Fang H; Wang X; Hu G; Wang Q; Xu W Bioorg Med Chem Lett; 2012 Jan; 22(2):850-3. PubMed ID: 22206607 [TBL] [Abstract][Full Text] [Related]
15. A Proteolytic Site-Directed Affinity Label to Inhibit the Human ATP-Dependent Protease Caseinolytic Complex XP. Sha Z; Chilakala S; Crabill G; Cheng I; Xu Y; Fishovitz J; Lee I Chembiochem; 2020 Jul; 21(14):2049-2059. PubMed ID: 32180302 [TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and biological evaluation of novel hybrid compounds of imidazole scaffold-based 2-benzylbenzofuran as potent anticancer agents. Wang XQ; Liu LX; Li Y; Sun CJ; Chen W; Li L; Zhang HB; Yang XD Eur J Med Chem; 2013 Apr; 62():111-21. PubMed ID: 23353748 [TBL] [Abstract][Full Text] [Related]
17. Discovery of novel indolin-2-one compounds as potent inhibitors of HsClpP for cancer treatment. Song R; Yang Y; Huang J; Qiao W; Luo B; Ju Y; Yang T; Luo Y Bioorg Chem; 2021 May; 110():104820. PubMed ID: 33773224 [TBL] [Abstract][Full Text] [Related]
18. HIF-1α inhibitors: synthesis and biological evaluation of novel moracin O and P analogues. Xia Y; Jin Y; Kaur N; Choi Y; Lee K Eur J Med Chem; 2011 Jun; 46(6):2386-96. PubMed ID: 21481991 [TBL] [Abstract][Full Text] [Related]
19. A Chemical Disruptor of the ClpX Chaperone Complex Attenuates the Virulence of Multidrug-Resistant Staphylococcus aureus. Fetzer C; Korotkov VS; Thänert R; Lee KM; Neuenschwander M; von Kries JP; Medina E; Sieber SA Angew Chem Int Ed Engl; 2017 Dec; 56(49):15746-15750. PubMed ID: 28906057 [TBL] [Abstract][Full Text] [Related]
20. Reversible inhibition of the ClpP protease via an N-terminal conformational switch. Vahidi S; Ripstein ZA; Bonomi M; Yuwen T; Mabanglo MF; Juravsky JB; Rizzolo K; Velyvis A; Houry WA; Vendruscolo M; Rubinstein JL; Kay LE Proc Natl Acad Sci U S A; 2018 Jul; 115(28):E6447-E6456. PubMed ID: 29941580 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]